Quality of life surveillance in Pariet b.i.d. therapy for refractory reflux esophagitis
Not Applicable
- Conditions
- Refractory Reflux Esophagitis
- Registration Number
- JPRN-jRCT1080221998
- Lead Sponsor
- Eisai Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 3750
Inclusion Criteria
Proton pump inhibitor-resistant reflux esophagitis.
(Patients who have mucosal breaks (erosions, ulcers) on endoscopy)
Exclusion Criteria
-Patients with a history of hypersensitivity to any ingredients of PARIET.
-Patients on atazanavir sulfate.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method